Most Recent

image: Opinion: Pressured to Commercialize

Opinion: Pressured to Commercialize

By | May 28, 2012

Is the push for science to save the still flailing economy a threat to scientific research?

5 Comments

image: 2012 Bio-Art Winners

2012 Bio-Art Winners

By | May 25, 2012

Check out the 10 images that won FASEB's first annual Bio-Art competition.

0 Comments

image: Could Stem Cells Cure MS?

Could Stem Cells Cure MS?

By | May 23, 2012

A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.

1 Comment

image: DNA Hard Drive

DNA Hard Drive

By | May 23, 2012

Researchers design the first rewritable biological data storage system.

2 Comments

image: Live Slow, Die Old

Live Slow, Die Old

By | May 17, 2012

Ancient bacteria living in deep-sea sediments are alive—but with metabolisms so slow that it’s hard to tell.

13 Comments

image: Synchronized Clocks

Synchronized Clocks

By | May 16, 2012

Researchers identify the first circadian clock component conserved across all three domains of life.

1 Comment

Rural Teens Have Fewer Allergies

By | May 8, 2012

The diversity of microbes in the great outdoors may protect against inflammatory disorders.

2 Comments

image: Gene Signaling by Remote

Gene Signaling by Remote

By | May 7, 2012

Nanoparticles in mice can be switched on to activate insulin production using a radio signal.

0 Comments

image: Six Threats to Chromosomes

Six Threats to Chromosomes

By | May 3, 2012

Researchers identify two new DNA repair systems, in addition to four that were already known, that can attack unprotected telomeres.

5 Comments

image: Nervous Mice Get Worse Cancer

Nervous Mice Get Worse Cancer

By | May 3, 2012

Anxious mice are more likely to come down with aggressive skin cancer than those who show less stress on behavioral tests.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech